Navigation Links
BioTrends Research Group, Inc. Recognized as One of Philadelphia's Fastest Growing Privately Held Companies
Date:10/27/2008

EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. was named one of the 2007 Top 100 fastest-growing, privately-held businesses in the Philadelphia region by the Philadelphia 100(R), a joint project of the Wharton Small Business Development Center, the Entrepreneurs' Forum of Greater Philadelphia, and the Philadelphia Business Journal. The rankings are based on verifiable revenue growth.

"This recognition is a testament to the uniqueness of our business model and the value that our reports and services provide to our clients," said Jennifer Robinson, founder and president of BioTrends.

BioTrends was founded in 2004 making this the first year that the company was eligible for nomination to the Philadelphia 100. BioTrends is a leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.

For more information about BioTrends, please visit http://www.bio-trends.com.

Contact:

Jennifer Robinson

BioTrends Research Group, Inc.

610-363-3872


'/>"/>
SOURCE BioTrends Research Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
2. BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
3. New Study by BioTrends Highlights Practice Management Shifts Among European Nephrologists
4. BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
5. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
6. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
7. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
8. Calvert Research and Auburn University Announce Joint Venture
9. Anti-Stem-Cell-Research Ad Ignores Facts
10. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
11. Researchers show how to stamp nanodevices with rubber molds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... ComplianceOnline, the leading governance, risk and compliance advisory network with ... Summit 2017 venue and speaker lineup. The Summit will take place on June 8 ... Omni Parker House Hotel, which is located at 60 School Street, Boston, MA will ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... instrumentation for cell-based assays, disperses a quarterly travel award to noteworthy scientists who ... the company announced that its new round of awards are being given to ...
(Date:3/29/2017)... and NEWARK, Del. , March 29, ... regenerative medicine company, and W. L. Gore ... today announced a collaborative research agreement whereby the two ... therapy delivery device technologies that provide protection from immune ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:3/29/2017)... India , March 29, 2017 The ... to 2022 report is a specialized and comprehensive study on the ... North America , Europe and ... Middle East and Africa ... Browse 172 ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
Breaking Biology News(10 mins):